• OPEN AN ACCOUNT
Indian Indices
Sensex
71,909.70 -570.59
( -0.79%)
Global Indices
Nasdaq
51,190.24 242.68
(0.48%)
Dow Jones
7,742.36 54.91
(0.71%)
Hang Seng
68,256.51 -700.21
(-1.02%)
Nikkei 225
10,455.36 27.09
(0.26%)
Forex
USD-INR
96.17 0.25
(0.26%)
EUR-INR
108.49 -0.30
(-0.28%)
GBP-INR
127.16 -0.03
(-0.02%)
JPY-INR
0.61 0.00
(-0.36%)

EQUITY - MARKET SCREENER

Lupin Ltd
Industry :  Pharmaceuticals - Indian - Bulk Drugs & Formln
BSE Code
ISIN Demat
Book Value()
500257
INE326A01037
658.9645485
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
LUPIN
14.01
92784.14
EPS(TTM)
Face Value()
Div & Yield %
144.8
2
0.89
 

Patel Engineering consolidated net profit rises 15.95% in the March 2026 quarter
May 14,2026
Net profit of Patel Engineering rose 15.95% to Rs 41.51 crore in the quarter ended March 2026 as against Rs 35.80 crore during the previous quarter ended March 2025. Sales declined 11.81% to Rs 1421.48 crore in the quarter ended March 2026 as against Rs 1611.86 crore during the previous quarter ended March 2025.

For the full year,net profit rose 7.69% to Rs 260.73 crore in the year ended March 2026 as against Rs 242.11 crore during the previous year ended March 2025. Sales rose 0.18% to Rs 5102.74 crore in the year ended March 2026 as against Rs 5093.36 crore during the previous year ended March 2025.

ParticularsQuarter EndedYear Ended
Mar. 2026Mar. 2025% Var.Mar. 2026Mar. 2025% Var.
Sales1421.481611.86 -12 5102.745093.36 0
OPM %15.1413.55 -13.4114.40 -
PBDT170.42164.92 3 553.35577.04 -4
PBT144.67138.98 4 449.68477.25 -6
NP41.5135.80 16 260.73242.11 8